CORE Biomedicine
PrivateLast Round
Series A
Jul 28, 2026
Total Funding Raised
$21M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
CORE Biomedicine is a biotechnology company that develops therapeutic approaches for the treatment of luminal cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CORE Biomedicine Comparables
Compare CORE Biomedicine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Flare Therapeutics | 83% | |
| Antares Therapeutics | 76% | |
| HotSpot Therapeutics | 73% |
CORE Biomedicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 28, 2026 | ||||
| Series A | Sep 13, 2025 | ||||
| Seed | Mar 14, 2025 |
CORE Biomedicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| YuanBio Venture Capital | Series A |
| Mitsubishi UFJ Capital | Series A |
| Root Venture Partners | Series A |
| Elēkrŏn Ventures | Series A |
| UTokyo Innovation Platform Co., Ltd. | Series A, Seed |
| Vision Incubate Co., Ltd. | Series A, Seed |
| CD Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
$21M round led by Elēkrŏn Ventures and UTokyo Innovation Platform.
- Sep 13, 2025
Raised Series A with UTokyo Innovation Platform and Vision Incubate.
CORE Biomedicine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CORE Biomedicine's valuation, stock price, and market status.
Is CORE Biomedicine a public or private company?
CORE Biomedicine is a private company.
What is the current stock price of CORE Biomedicine?
CORE Biomedicine is a private company, so its shares have no public market price. Caplight tracks CORE Biomedicine's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CORE Biomedicine worth (valuation)?
Valuation information for CORE Biomedicine is not publicly available.
Can I buy CORE Biomedicine stock?
CORE Biomedicine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CORE Biomedicine's last funding round?
CORE Biomedicine's most recent funding round was Series A on July 28, 2026.
Who are the main investors in CORE Biomedicine?
Key investors in CORE Biomedicine include Elēkrŏn Ventures, UTokyo Innovation Platform Co., Ltd..
Will CORE Biomedicine IPO soon?
No public IPO plans have been announced for CORE Biomedicine.
How can I track CORE Biomedicine secondary market activity?
Caplight tracks bids, offers, and trades in CORE Biomedicine's shares on secondary markets.